Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF OPERATIONS

v3.7.0.1
CONDENSED STATEMENT OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating expenses:    
Research and development $ 133 $ 564
General and administration 371 276
Loss from operations (504) (840)
Interest expense 95 85
Interest expense - related party 61 33
Change in fair value of convertible notes payable 4 89
Change in fair value of warrant liabilities (3) 0
Net Loss $ (661) $ (1,047)
Net loss per common share outstanding, basic and diluted $ (0.07) $ (0.13)
Weighted average number of common shares outstanding, basic and diluted 9,068,539 8,310,604